Central Bank & Trust’s Allergan Inc AGN Stock Holding History

Central Bank & Trust’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-21,292	Closed	-$4.53M	–	366
2014 Q4	$4.53M	Buy	21,292 +156	+0.7%	+$31K	1.55%	20
2014 Q3	$3.77M	Buy	21,136 +3,742	+22%	+$621K	1.42%	20
2014 Q2	$1.93M	Sell	17,394 -1,597	-8%	-$249K	0.75%	51
2014 Q1	$2.36M	Buy	18,991 +1,597	+9%	+$194K	0.92%	41
2013 Q4	$1.93M	Buy	17,394 +2,290	+15%	+$219K	0.75%	51
2013 Q3	$1.37M	Buy	15,104 +4,182	+38%	+$375K	0.61%	61
2013 Q2	$921K	Buy	+10,922	New	+$1.13M	0.44%	73

Other funds holding AGN

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

HFS

HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Central Bank & Trust's AGN Position: Q1 2015 in Review

Central Bank & Trust sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 21,292 shares — an estimated $4.53M sold.

Central Bank & Trust first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $4.53M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

Central Bank & Trust reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
Central Bank & Trust sold 21,292 Allergan Inc shares in Q1 2015, an estimated $4.53M.
Central Bank & Trust first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
Central Bank & Trust's Allergan Inc position peaked at $4.53M in Q4 2014.
5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Central Bank & Trust's 13F filing for Q1 2015, filed 21 Apr 2015.